This compound is a pharmaceutical impurity reference standard, specifically identified as Trilaciclib Impurity 3. It is a spirocyclic sulfone derivative used in analytical testing and quality control for pharmaceutical manufacturing.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing Trilaciclib Impurity 3?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.
Benzyl (2S)-2-{8-aminoimidazo[1,5-a]pyrazin-3-yl}pyrrolidine-1-carboxylate
pharmaceutical intermediate
Fmoc-Ile-Aib-OH
pharmaceutical intermediate
((3aS,5R,6S,6aS)-6-(benzyloxy)-2,2-dimethyltetrahydrofuro[2,3-d][1,3]dioxol-5-yl)(morpholino)methanone
pharmaceutical intermediate
((((E)-2-((2R,3R,4R,5R)-3-(((2-CYANOETHOXY)(DIISOPROPYLAMINO)PHOSPHINO)OXY)-5-(2,4-DIOXO-3,4-DIHYDROPYRIMIDIN-1(2H)-YL)-4-METHOXYTETRAHYDROFURAN-2-YL)VINYL)PHOSPHORYL)BIS(OXY))BIS(METHYLENE) BIS(2,2-DIMETHYLPROPANOATE)
pharmaceutical intermediate
Trilaciclib Impurity 36
pharmaceutical intermediate
4-methylsulfanylspiro[1,3,5,11-tetrazatricyclo[7.4.0.02,7]trideca-2,4,6,8-tetraene-13,1'-cyclohexane]-10-one
research compound
Trilaciclib Impurity 35
pharmaceutical intermediate
Tert-butyl 4-methylsulfanyl-10-oxo-8-(trifluoromethylsulfonyloxy)spiro[1,3,5,11-tetrazatricyclo[7.4.0.02,7]trideca-2,4,6,8-tetraene-13,1'-cyclohexane]-11-carboxylate
research intermediate
4-methylsulfonylspiro[1,3,5,11-tetrazatricyclo[7.4.0.02,7]trideca-2,4,6,8-tetraene-13,1'-cyclohexane]-10-one
FDAWWCDPKPAZSB-UHFFFAOYSA-N
CS(=O)(=O)C1=NC=C2C=C3C(=O)NCC4(N3C2=N1)CCCCC4
Sourcing Trilaciclib Impurity 3?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.